Report Detail
Global Multiple Myeloma Drugs Market Professional Survey Report 2019
- RnM3810589 |
- 09 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
Multiple myeloma is a cancer that forms in a type of white blood cell that is called a plasma cell. Plasma cells help to fight infections by making antibodies. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can cause complications. For people with multiple myeloma who require treatment, a number of treatments are available to help control the disease.
Cancer cells have higher levels of proteasome activity are more sensitive to the proapoptotic effects of proteasome inhibition than normal cells, which makes the proteasome a therapeutic target in multiple myeloma. Proteasome inhibitor treatment is preferred after there is a treatment failure with the conventional approach.
The global Multiple Myeloma Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Multiple Myeloma Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Multiple Myeloma Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Multiple Myeloma Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Multiple Myeloma Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen
Johnson & Johnson
Celgene
Takeda Pharmaceutical
Novartis
Daiichi Sankyo
Merck
AB Science
Teva
PharmaMar
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Immunomodulatory drugs (IMiDs)
Proteasome inhibitors
Chemotherapy
Histone deacetylase inhibitor (HDAC inhibitor)
Steroids (corticosteroids)
Segment by Application
Men
Women
Table of Contents
Executive Summary
1 Industry Overview of Multiple Myeloma Drugs
- 1.1 Definition of Multiple Myeloma Drugs
- 1.2 Multiple Myeloma Drugs Segment by Type
- 1.2.1 Global Multiple Myeloma Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Immunomodulatory drugs (IMiDs)
- 1.2.3 Proteasome inhibitors
- 1.2.4 Chemotherapy
- 1.2.5 Histone deacetylase inhibitor (HDAC inhibitor)
- 1.2.6 Steroids (corticosteroids)
- 1.3 Multiple Myeloma Drugs Segment by Applications
- 1.3.1 Global Multiple Myeloma Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Men
- 1.3.3 Women
- 1.4 Global Multiple Myeloma Drugs Overall Market
- 1.4.1 Global Multiple Myeloma Drugs Revenue (2014-2025)
- 1.4.2 Global Multiple Myeloma Drugs Production (2014-2025)
- 1.4.3 North America Multiple Myeloma Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Multiple Myeloma Drugs Status and Prospect (2014-2025)
- 1.4.5 China Multiple Myeloma Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Multiple Myeloma Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Multiple Myeloma Drugs Status and Prospect (2014-2025)
- 1.4.8 India Multiple Myeloma Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs
- 2.3 Manufacturing Process Analysis of Multiple Myeloma Drugs
- 2.4 Industry Chain Structure of Multiple Myeloma Drugs
3 Development and Manufacturing Plants Analysis of Multiple Myeloma Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Multiple Myeloma Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Multiple Myeloma Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Multiple Myeloma Drugs Production and Capacity Analysis
- 4.2 Multiple Myeloma Drugs Revenue Analysis
- 4.3 Multiple Myeloma Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Multiple Myeloma Drugs Regional Market Analysis
- 5.1 Multiple Myeloma Drugs Production by Regions
- 5.1.1 Global Multiple Myeloma Drugs Production by Regions
- 5.1.2 Global Multiple Myeloma Drugs Revenue by Regions
- 5.2 Multiple Myeloma Drugs Consumption by Regions
- 5.3 North America Multiple Myeloma Drugs Market Analysis
- 5.3.1 North America Multiple Myeloma Drugs Production
- 5.3.2 North America Multiple Myeloma Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Multiple Myeloma Drugs Import and Export
- 5.4 Europe Multiple Myeloma Drugs Market Analysis
- 5.4.1 Europe Multiple Myeloma Drugs Production
- 5.4.2 Europe Multiple Myeloma Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Multiple Myeloma Drugs Import and Export
- 5.5 China Multiple Myeloma Drugs Market Analysis
- 5.5.1 China Multiple Myeloma Drugs Production
- 5.5.2 China Multiple Myeloma Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Multiple Myeloma Drugs Import and Export
- 5.6 Japan Multiple Myeloma Drugs Market Analysis
- 5.6.1 Japan Multiple Myeloma Drugs Production
- 5.6.2 Japan Multiple Myeloma Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Multiple Myeloma Drugs Import and Export
- 5.7 Southeast Asia Multiple Myeloma Drugs Market Analysis
- 5.7.1 Southeast Asia Multiple Myeloma Drugs Production
- 5.7.2 Southeast Asia Multiple Myeloma Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Multiple Myeloma Drugs Import and Export
- 5.8 India Multiple Myeloma Drugs Market Analysis
- 5.8.1 India Multiple Myeloma Drugs Production
- 5.8.2 India Multiple Myeloma Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Multiple Myeloma Drugs Import and Export
6 Multiple Myeloma Drugs Segment Market Analysis (by Type)
- 6.1 Global Multiple Myeloma Drugs Production by Type
- 6.2 Global Multiple Myeloma Drugs Revenue by Type
- 6.3 Multiple Myeloma Drugs Price by Type
7 Multiple Myeloma Drugs Segment Market Analysis (by Application)
- 7.1 Global Multiple Myeloma Drugs Consumption by Application
- 7.2 Global Multiple Myeloma Drugs Consumption Market Share by Application (2014-2019)
8 Multiple Myeloma Drugs Major Manufacturers Analysis
- 8.1 Amgen
- 8.1.1 Amgen Multiple Myeloma Drugs Production Sites and Area Served
- 8.1.2 Amgen Product Introduction, Application and Specification
- 8.1.3 Amgen Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Multiple Myeloma Drugs Production Sites and Area Served
- 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.2.3 Johnson & Johnson Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Celgene
- 8.3.1 Celgene Multiple Myeloma Drugs Production Sites and Area Served
- 8.3.2 Celgene Product Introduction, Application and Specification
- 8.3.3 Celgene Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Takeda Pharmaceutical
- 8.4.1 Takeda Pharmaceutical Multiple Myeloma Drugs Production Sites and Area Served
- 8.4.2 Takeda Pharmaceutical Product Introduction, Application and Specification
- 8.4.3 Takeda Pharmaceutical Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Novartis
- 8.5.1 Novartis Multiple Myeloma Drugs Production Sites and Area Served
- 8.5.2 Novartis Product Introduction, Application and Specification
- 8.5.3 Novartis Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Daiichi Sankyo
- 8.6.1 Daiichi Sankyo Multiple Myeloma Drugs Production Sites and Area Served
- 8.6.2 Daiichi Sankyo Product Introduction, Application and Specification
- 8.6.3 Daiichi Sankyo Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Merck
- 8.7.1 Merck Multiple Myeloma Drugs Production Sites and Area Served
- 8.7.2 Merck Product Introduction, Application and Specification
- 8.7.3 Merck Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 AB Science
- 8.8.1 AB Science Multiple Myeloma Drugs Production Sites and Area Served
- 8.8.2 AB Science Product Introduction, Application and Specification
- 8.8.3 AB Science Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Teva
- 8.9.1 Teva Multiple Myeloma Drugs Production Sites and Area Served
- 8.9.2 Teva Product Introduction, Application and Specification
- 8.9.3 Teva Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 PharmaMar
- 8.10.1 PharmaMar Multiple Myeloma Drugs Production Sites and Area Served
- 8.10.2 PharmaMar Product Introduction, Application and Specification
- 8.10.3 PharmaMar Multiple Myeloma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Multiple Myeloma Drugs Market
- 9.1 Global Multiple Myeloma Drugs Market Trend Analysis
- 9.1.1 Global Multiple Myeloma Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Multiple Myeloma Drugs Regional Market Trend
- 9.2.1 North America Multiple Myeloma Drugs Forecast 2019-2025
- 9.2.2 Europe Multiple Myeloma Drugs Forecast 2019-2025
- 9.2.3 China Multiple Myeloma Drugs Forecast 2019-2025
- 9.2.4 Japan Multiple Myeloma Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Multiple Myeloma Drugs Forecast 2019-2025
- 9.2.6 India Multiple Myeloma Drugs Forecast 2019-2025
- 9.3 Multiple Myeloma Drugs Market Trend (Product Type)
- 9.4 Multiple Myeloma Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Multiple Myeloma Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Multiple Myeloma Drugs. Industry analysis & Market Report on Multiple Myeloma Drugs is a syndicated market report, published as Global Multiple Myeloma Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Multiple Myeloma Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
